UPC_APP_27016/2025

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Procedural & sub-applicationsCase Management OrdersThe Hague LDApplication Rop 333—

Overview Decisions Documents Timeline

Parties

Claimants

Arbutus Biopharma Corporation
Genevant Sciences GmbH

Reps: Markus van Gardingen (Not specified)

Respondents

Moderna, Inc.(Moderna Group)
ModernaTX, Inc.(Moderna Group)
Moderna Belgium S.R.L.(Moderna Group)
Moderna Italy S.R.L.(Moderna Group)
Moderna France SASU(Moderna Group)
Moderna Biotech UK Limited(Moderna Group)
Moderna Switzerland GmbH(Moderna Group)
Moderna Poland SP. Z.O.O.(Moderna Group)
Moderna Portugal Unipessoal LDA(Moderna Group)
Moderna Sweden AB(Moderna Group)
Moderna Netherlands B.V.(Moderna Group)
Moderna Biotech Spain SL(Moderna Group)
Moderna Denmark ApS(Moderna Group)
Moderna Germany GmbH(Moderna Group)
Moderna Norway AS(Moderna Group)

Reps: Ruben Laddé (Not specified); Joachim Renken (Not specified)

Judges

Not SpecifiedJudge-Rapporteur (The Hague Local Division)

Patents

EP 2 279 254
EP 4 241 767

CPC codes: C07J9/00, A61P31/14, A61K9/1271, C12N15/111, C12N2310/14, C12N15/113, A61K9/1272, A61P35/00, A61K31/713, C12N2320/32, A61P31/12, C12N15/1137…

Sector: Biotechnology

Outcome

Procedural only

Filed: —

First decided: Jun 12, 2025

Language: —